Michael Leo West

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Alchemia Limited, Alchemia Pty Ltd, Dr. Reddy's Laboratories, Incorporated. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Leo West. Retrieved from https://idiyas.com/inventor/michael-leo-west

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 33.3

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Queensland, AU (2008 - 2012)
Hemmant, AU (2007 - 2014)
Birkdale, AU (2009 - 2016)

Company Filing History:

Dr. Reddy's Laboratories, Incorporated

patents

Years Active: 2007-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9243018 - Synthetic heparin pentasaccharides (2016-01-26),

2. 8686131 - Synthetic heparin trisaccharides (2014-04-01),

3. 8673586 - Compounds that interact with kinases (2014-03-18),

4. 8404833 - Synthetic heparin disaccharides (2013-03-26),

5. 8222381 - Derivatives of monosaccharides for drug discovery (2012-07-17),

6. 8114970 - Synthetic heparin monosaccharides (2012-02-14),

7. 8093227 - Monosaccharide compounds and methods therefor (2012-01-10),

8. 7875707 - Disaccharides for drug discovery (2011-01-25),

9. 7737287 - Anomeric derivatives of monosaccharides (2010-06-15),

10. 7541445 - Synthetic heparin pentasaccharides (2009-06-02),

11. 7417129 - Combinatorial libraries of monosaccharides (2008-08-26),

12. 7291623 - Compounds that interact with kinases (2007-11-06),

Title: Michael Leo West – Innovator in Synthetic Heparinoids

Introduction

Michael Leo West is a notable inventor based in Birkdale, Australia, recognized for his significant contributions in the field of synthetic heparinoids. With a remarkable portfolio comprising 12 patents, he has played a pivotal role in advancing research and application in this vital area of biochemistry.

Latest Patents

West's latest patents include innovations focused on synthetic heparin pentasaccharides and synthetic heparin trisaccharides. His patent on synthetic heparin pentasaccharides details the preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides, and pentasaccharides that are essential for synthesizing heparinoids. The patent concerning synthetic heparin trisaccharides emphasizes the preparation of synthetic trisaccharides that are useful for creating heparinoids, showcasing his expertise in this niche area.

Career Highlights

Throughout his career, Michael West has contributed to key companies that have propelled his innovations. Notably, he has worked with Alchemia Limited and Alchemia Pty Ltd, where he applied his knowledge in a collaborative environment that fostered research and development in medicinal chemistry.

Collaborations

Working alongside talented colleagues, West has collaborated with notable professionals such as Wim F Meutermans and Tracie E Ramsdale. These partnerships have enriched his research and development processes, leading to the creation of impactful patents and further innovations in synthetic biochemistry.

Conclusion

Michael Leo West's inventive journey continues to make strides in the field of synthetic heparinoids. With multiple patents and a strong collaborative network, he exemplifies the spirit of innovation. His work not only enhances the understanding of synthetic compounds but also opens new avenues for therapeutic applications in medicine.

Profile summary based on public USPTO records.